ALNY - Alnylam Pharmaceuticals Non-GAAP EPS of -$0.16 beats by $0.32 revenue of $494.3M beats by $67.44M
2024-05-02 08:02:06 ET
More on Alnylam Pharmaceuticals
- Is Alnylam's HELIOS-B Delay A Red Flag?
- Alnylam Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2023 Earnings Call Transcript
- Alnylam Pharmaceuticals Q1 2024 Earnings Preview
- Alnylam, Roche mark second Phase 2 win for blood pressure therapy